4.4.2. Parkinson's disease
| Pack |
|---|
| 5 pre-filled disposable injection |
| Pack |
|---|
| 5 ampoule |
| Pack |
|---|
| 100 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| 20 capsule |
| Pack |
|---|
| 8 tablet |
| Pack |
|---|
| 20 tablet |
| 30 tablet |
| Pack |
|---|
| 20 tablet |
| 30 tablet |
| 60 tablet |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 tablet |
| Pack |
|---|
| 90 tablet (9 x 10 tablets) |
| Pack |
|---|
| 50 tablet |
| 90 tablet |
| Pack |
|---|
| 60 tablet |
| Pack |
|---|
| 60 tablet |
| Pack |
|---|
| 100 tablet |
2nd line after trial with entacapone only if patient unable to tolerate entacapone
| Pack |
|---|
| 30 capsule |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| Pack |
|---|
| 105 tablet |
| Pack |
|---|
| 21 tablet |
| 42 tablet |
| 84 tablet |
| Pack |
|---|
| 21 tablet |
| 28 tablet |
| 63 tablet |
| 84 tablet |
| Pack |
|---|
| 21 tablet |
| 84 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 patch |
| Pack |
|---|
| 28 patch |
| 7 patch |
| Pack |
|---|
| 28 patch |
| 7 patch |
| Pack |
|---|
| 28 patch |
| 7 patch |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| 56 tablet |
| 60 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| Pack |
|---|
| 100 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| 84 tablet |
| Pack |
|---|
| 100 tablet |
| 84 tablet |
Only for initiation by specialists in Neurology & Healthcare of Older People and continued in primary care.
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only